Wplyw wysokich dawek pokarmowych chromu [III] i kwercetyny na wybrane wskazniki biochemiczne krwi u szczura

• Autorzy: Staniek H , Krejpcio Z. , Szymusiak H. , Zielinski R.

Warianty tytułu

EN

The effect of high dietary doses of chromium [III] and quercetin on selected blood biochemical indices in rat

• Języki publikacji: PL

Abstrakty

PL

Celem badań było określenie wpływu wysokich dawek pokarmowych Cr(III) bez i w obecności kwercetyny na organizm szczura. W 4 tygodniowym doświadczeniu biologicznym szczury rasy Wistar żywiono dietą Labofeed H z dodatkiem kompleksu Cr(III) z kwasem propionowym (1000 mg Cr/kg diety) bez i w obecności równomolowej ilości kwercetyny. Stwierdzono, że wysokie dawki pokarmowe Cr(III) nie wpływały istotnie na poziom wskaźników biochemicznych krwi, natomiast te same dawki Cr(III) w obecności kwercetyny istotnie obniżały stężenie glukozy i triglicerydów w surowicy krwi u szczura.

EN

The purpose of this study was to evaluate the effect of dietary Cr(III), with and without the presence of quercetin on blood biochemical indices in rats. It was found that high doses of Cr(III) complex with propionic acid given per os (1000 mg Cr/kg diet) did not affect significantly blood indices, however Cr(III) in the presence of equimolar amounts of quercetin significantly decreased blood glucose and trigicerydes concentrations in rats.

Słowa kluczowe

PL

szczury; wskazniki biochemiczne; krew; chrom; zwierzeta laboratoryjne; dawki pokarmowe; kwercetyna

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2007
• Tom: 34
• Numer: 3-4
• Opis fizyczny: s.1069-1073,tab.,bibliogr.

Twórcy

autor

Staniek H

• Akademia Rolnicza im.Augusta Cieszkowskiego, Poznan

autor

Krejpcio Z.

autor

Szymusiak H.

autor

Zielinski R.

Bibliografia

• 1. Anderson R.A., Bryden N.A., Polansky M.M.: Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr., 1997, 3(16), 273.
• 2. Bolkent S., Yanardar R., Doger M.M.: Benefical effects of combined treatment with niacin and chromium on the liver of hiperlipemic rats. Biol. Trace Elem. Res., 2004, 101(3), 219.
• 3. Clodfelder B.J., Chang C., Vincent J.B.: Absorption of the biomimetic chromium cation triaqua-µ3-oxo- hexapropioniatotrichromium(III) in rats. Biol. Trace Elem. Res., 97, 2004, 1.
• 4. Czerny B., Put A., Myśliwiec Z. et al.: The influence of quercetin on some biochemical parameters in rats exposed to environmental contamination with fluorine compounds. Pol. J. Environ. Stud., 2000, 9(3), 157.
• 5. Eamshaw A., Figgis B.N., Lewis J.: Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimeric chromium and iron carboxylates. J. Chem. Soc. A. 1966, 1656.
• 6. Erlund I., Kosonen T., Alfthan G. et al.: Pharmacokinetics of querctin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol., 2000, 56, 545.
• 7. Hepburn D.D.D., Burney J.M., Woski S.A. et al.: The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vitro. Polyhedron, 2003, 22, 455.
• 8. Hertog M.G.L., Kromhout D., Aravanis C. et al.: Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Inter. Med., 1995, 155, 381.
• 9. Kanter M., Altan M.F., Donmez S. et al.: The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct., 2007, 31.
• 10. Knekt P., Jarvinen R., Seppanen R. et al.: Dietary flavonoids and risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol., 1997, 146, 223.
• 11. Newman D.J., Price C.P.: Renal function and nitrogen metabolites. In Burtis C.A., Ashwood E.R., eds.: Tietz textbook of clinical chemistry. Philadelphia: WB Saunders Company, 1999, 1239.
• 12. Krejpcio Z., Szymusiak H., Zieliński R., i in.: Biological properties of chromium(III) in the presence of quercetin. The 15th Symposium of IGWT, Global safety of commodity and environment. Quality of life. Kyiv, Ukraine, 2006, 687.
• 13. Liu Y., Hu M.: Absorption and metabolism of flavonoids in the Caco-2-cell culture model and a perused rat intestinal model. Drug Matabolism and Disposition, 2002, 30, 370.
• 14. Miki Y.: A homogenous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method. Clin. Lab. 1999, 45, 398.
• 15. Podstawy toksykologii. Praca zbiorowa red. J.K. Piotrowski. Wydawnictwo Naukowo Techniczne, Warszawa 2006.
• 16. Ramana B.V., Kumar V.V., Krishna P.N.R. et al.: Effect of quercetin on galactose-induced hyperglycaemic oxidative stress in hepatic and neuronal tissues of Wistar rats. Acta Diabetol., 2006, 43, 135.
• 17. Riesen W.F.: Lipid Metabolism. Thomas L, ed. Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. FrankfurtMain: TH-Books Verlagssesellschaft 1998, 167.
• 18. Sacks D.B., Bruns D.E., Goldstein D.E., et al.: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin. Chem. 2002, 48, 436.
• 19. Shephard M.D., Whiting M.J.: Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder’s chromogen. Clin. Chem., 1990, 36, 325.
• 20. Shindea U.A., Sharma G., Xu Y.J. et al.: Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus. J. Trace Elem. Med. Biol., 2004, 18(1), 23.
• 21. Speetjens J.K., Collins R.A., Vincent J.B. et al.: The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem. Res. Toxicol. 1999A, 12, 483.
• 22. Speetjens J.K., Parand A., Crowder M.W. et al.: Low-molecular-weight, chromium-binding substance and biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ do not cleave DNA under physiologically relevant conditions. Polyhedron, 1999b, 18, 2617.
• 23. Stearns D.M., Wise J.P., Patierno S.R. et al.: Chromium(III) picoliniate produces chromosome damage in Chinese hamster overy cells. FASEB, 1995, 9, 15, 1643.
• 24. Schumann G., Klauke R.: New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin. Chim. Acta, 2003, 327, 69.
• 25. Thomas L.: Total protein. In Thomas L., ed. Clinical laboratory diagnostics. Use and assessment of clinical laboratory results. FrankfurtMain: TH -Books Verlagsgesllschaft 1998, 644.
• 26. Wu Y.T., Sun Z., Che S.P. et al.: Regulation of chromium on gene expression of skeletal muscles in diabetic rats. Wei Sheng Yan Jiu, 2005, 34(2), 184.
• 27. Yang X., Palanichamy K., Ontko A.C. et al.: A newly synthetic chromium complex-chromium(phenylalanine)3 improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Lett., 2005, 28, 579, 1458.
• 28. Vincent J.B.: Review. Recent Developments in the Biochemistry of Chromium(III). Biol. Trace Elem. Res., 2004, 99, 1.
• 29. Wybieralska K.: Wpływ jonów magnezu(II), żelaza(II) i żelaza(III) na aktywność przeciwrodnikową kwercetyny. Towaroznawcze Problemy Jakości, 2006, 1(6), 48.